Previous studies showed that an elevated expression of ATP6V0D2 was found in stomach cancer specimens, whereas the expression was reduced in the colorectal and renal cancer specimens, which confirmed our findings [50, 51]. This evidence concerns the gene ATP6V0D2 and renal carcinoma.